Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LONDON and RALEIGH, N.C., Sept. 06, 2023 Verona Pharma plc , announces an oral presentation on an additional analysis from its successful Phase 3 ENHANCE-1 study with ensifentrine for the.
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PDE3.
LONDON and RALEIGH, N.C., Aug. 31, 2023 Verona Pharma plc , announces effective September 1, 2023, Ms. Christina Ackermann will join the board as a Non-Executive Director. Ms. Ackermann brings.
Christina Ackermann Joins Verona Pharma as Non-Executive Director itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.